Skip to Main Content
Table 1.

Characterization of the primer sets used for the analysis of AI

MarkerChrom. RegionDescription
D6S474 6q21-22 BFD4 (Body fluid distribution QTL 4) 
D6S1631 6q16 Transforming growth factor-β–activating kinase 
D7S522 7q31.1 Caveolin 1 
D8S87 8p12 Neuregulin 1 
D8S137 8p21.1 Dematin 
D8S286 8q21.3 HNF-4γ (Hepatocyte nuclear factor-4γ) 
D8S360 8p21 n.a 
D9S171 9p21-22 CDKN2/p16 
D9S1748 9p21 CDKN2/p16 
D10S1765 10q23.3 PTEN (Phosphatase and tensin homologue) 
D10S541 10q23 PTEN 
D11S898 11q22 n.a. 
D11S1313 11q12-13 CORS2 (Cerebello-oculo-renal syndrome 2) 
D17S1855 17q21 BRCA1 (Breast cancer type 1) 
MarkerChrom. RegionDescription
D6S474 6q21-22 BFD4 (Body fluid distribution QTL 4) 
D6S1631 6q16 Transforming growth factor-β–activating kinase 
D7S522 7q31.1 Caveolin 1 
D8S87 8p12 Neuregulin 1 
D8S137 8p21.1 Dematin 
D8S286 8q21.3 HNF-4γ (Hepatocyte nuclear factor-4γ) 
D8S360 8p21 n.a 
D9S171 9p21-22 CDKN2/p16 
D9S1748 9p21 CDKN2/p16 
D10S1765 10q23.3 PTEN (Phosphatase and tensin homologue) 
D10S541 10q23 PTEN 
D11S898 11q22 n.a. 
D11S1313 11q12-13 CORS2 (Cerebello-oculo-renal syndrome 2) 
D17S1855 17q21 BRCA1 (Breast cancer type 1) 

Abbreviations: Chrom. region, chromosome region; n.a., not analyzed.

Close Modal

or Create an Account

Close Modal
Close Modal